Skip to Main Content
Pharmacy Technician's Letter Canada
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • Natural Medicines
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • CE & Training
    • CE Organizer
    • Available Courses
    • Live CE Calendar
    • Print Statements
    • Licenses
    • Additional Requirements
    • Exemptions
  • New Drugs
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Psychiatry
  4. Resources
  5. Drugs

Drugs

  • ADHD (48)
  • Anxiety (26)
  • Bipolar Disorder (10)
  • Depression (180)
  • Mental Health (23)
  • Resources (103)
    • Charts (28)
    • Drugs (33)
      • Anti-Anxiety Drugs (4)
      • Antidepressants (14)
      • Antipsychotics (20)
      • Mood Stabilizers (4)
    • Guidelines (24)
    • Patient Education (7)
    • PL Voices (24)
    • Quality Measures (3)
  • Schizophrenia (42)
  • Sleep Disorders (66)
  • Substance Use Disorder (149)
31 - 33 of 33 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: The new Abilify Maintena (aripiprazole) will put more focus on avoiding mix-ups with intramuscular "atypical" antipsychotics May 2014
Article: Health Canada is warning about the possibility that lithium might increase a patient's blood level of calcium April 2014
Article: "atypical antipsychotics" (olanzapine, ziprasidone, etc) are being overused December 2013
  • « Prev
  • 1
  • 2
  • 3
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved